Severe precocious emphysema in intravenous methylphenidate (Ritalin) abusers.

Area of Science:

• Pulmonary Medicine
• Toxicology
• Cardiovascular Research

Background:

• Intravenous drug abuse is associated with pulmonary complications like granulomatosis.
• Pulmonary vascular sclerosis has been reported in long-term intravenous methylphenidate users.
• Obstructive lung disease is an unexpected outcome, contrasting with the typical restrictive lung disease expected from vascular changes.

Purpose of the Study:

• To report a series of patients with severe obstructive lung disease linked to long-term intravenous methylphenidate use.
• To investigate a potential association between methylphenidate abuse and early-onset severe obstructive lung disease.

Main Methods:

• Case series of six patients with a history of long-term intravenous methylphenidate abuse.
• Clinical assessment of respiratory symptoms and airflow obstruction.
• Review of potential contributing factors including smoking.

Main Results:

• All six patients exhibited severe obstructive lung disease after using intravenous methylphenidate for at least four years.
• One patient died from respiratory insufficiency; others are clinically disabled.
• Symptoms and airflow obstruction severity exceeded that typically seen in chronic obstructive pulmonary disease.

Conclusions:

• A cluster of severe obstructive lung disease cases among intravenous methylphenidate abusers suggests a possible drug-induced etiology.
• While other factors like smoking cannot be excluded, long-term intravenous methylphenidate exposure may contribute to precocious obstructive lung disease.